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The gonococcal porA pseudogene is a popular target 
for in-house Neisseria gonorrhoeae PCR methods. 
With this study we present two novel findings: the 
first case of an N. gonorrhoeae porA pseudogene PCR 
false-negative result caused by sequence variation, 
and in the same organism, the first description of a 
clinical N. gonorrhoeae strain harbouring an N. menin-
gitidis porA sequence.
In this report, we describe the first case of a Neisseria 
gonorrhoeae false-negative test result using an N. 
gonorrhoeae porA pseudogene PCR method, caused 
by sequence variation. Nucleic acid amplification tests 
(NAATs) are widely used for the detection of gonor-
rhoea, yet there are challenges for N. gonorrhoeae 
NAATs because of the considerable sequence variation 
and genetic exchange that is exhibited by the Neisseria 
genus. Many gonococcal NAATs are known to cross-
react with commensal Neisseria strains necessitating 
the use of supplementary testing [1,2]. In addition, 
sequence-related false-negative results have also 
been reported for NAATs targeting certain gonococcal 
sequences. These include the N. gonorrhoeae cppB 
and opa genes [3,4]. 
In March 2011, a young man in his early 20s presented 
with anal pain to a sexual health clinic in Newcastle, 
New South Wales, Australia.  The man reported hav-
ing recently had numerous sexual contacts with men 
(MSM), some with overseas visitors, including from the 
United States, but reported no recent overseas travel. 
Pharyngeal and rectal swabs, as well as a urine sample 
were obtained and submitted for N. gonorrhoeae test-
ing. The urine sample and rectal swab were tested by 
NAAT, and both swab samples were tested by bacterial 
culture. A summary of results is provided in the Table. 
The rectal swab provided positive results for N. 
gonorrhoeae by Cobas4800 CT/NG testing (Roche 
Diagnostics, Australia) which targets a direct repeat 
Table 
Culture and NAAT results for Neisseria gonorrhoeae by anatomical site and type of sample, New South Wales, Australia, 
March 2011
Anatomical site / 
type of sample
Neisseria gonorrhoeae diagnostic methods
Culture Cobas4800 CT/NG LightCycler PCR (porA pseudogene)
TaqMan PCR 
(porA pseudogene)
Urine sample NP Negative NP NP
Rectal swab Positive Positive Negative Negative
Rectal isolate NA Positive Negative Negative
Pharyngeal swab Positive NP NP NP
Pharyngeal isolate NA Positive Negative Negative
NA: not applicable; NAAT: nucleic acid amplification test; NP: not performed.
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region, DR-9, with a cycle threshold value of 27, and N. 
gonorrhoeae was subsequently isolated from both the 
pharyngeal and rectal swabs. The urine sample was 
negative by NAAT (Cobas4800). Following Australian 
public health laboratory network guidelines [2] which 
require supplementary testing for N. gonorrhoeae 
NAAT-positive samples, a DNA extract from the rectal 
sample was tested using a LightCycler-hybridisation 
probe-based PCR protocol targeting the gonococcal 
porA pseudogene [5]. The porA pseudogene is a target 
widely used for this purpose and has previously been 
shown to be highly conserved and specific to N. gonor-
rhoeae [5-8]. Negative results were obtained using the 
LightCycler method for both the DNA extract of the rec-
tal swab as well as the clinical isolates cultured from 
the pharyngeal and rectal sites. When the rectal sam-
ple and the rectal and pharyngeal isolates were subse-
quently tested using a TaqMan-based N. gonorrhoeae 
porA pseudogene (porA-monoplex) assay, the results 
were also negative [8]. Testing of the clinical isolates 
using the Cobas4800 CT/NG assay provided positive 
results for N. gonorrhoeae, with cycle threshold values 
of 17 for both isolates. 
The clinical isolates were further characterised pheno-
typically and genotypically. Both isolates were indis-
tinguishable and were identified phenotypically [9] as 
N. gonorrhoeae by Gram stain, colonial morphology 
on modified New York City agar, oxidase, superoxol 
and rapid carbohydrate utilisation tests. The isolates 
were tested for prolyliminopeptidase (PIP) activity, 
auxotyped, serogrouped and the serovar determined 
by coagglutination reactions with 14 monoclonal rea-
gents (Boule, Huddinge, Sweden). Both isolates tested 
positive for PIP, were prototrophs and belonged to a 
common serovar, ‘Bropyst’. An identification of N. gon-
orrhoeae was also provided by the Bruker Biotyper 
matrix-assisted laser desorption ionisation time of 
Figure
Sequence alignment of porA sequences of Neisseria gonorrhoeae FA1090 straina, N. gonorhoeae porA-variantb and 
N. meningitidis 278 strainc
10        20 30        40        50        60        70        80        90
N.gonorrhoeae (FA1090) TTGGCAGCTCGAGCAAGACGTATCCGTTGCCGGCGGCGGCGCGACCCGTTGGGGTAACAGGGAATCCTTTATCGGCTTGGCAGGCGAATT
N.gonorrhoeae (variant) .........T.....................................AG.....C...................................
N.meningitidis (278) .........T.....................................AG.....C...................................
100       110       120       130 140       150       160       170       180
N.gonorrhoeae (FA1090) CGGCACGGCGCTCGCCGGTCGCGTTGCGAATCCGTTTGGCGATGCCAGCAAAGCCATTGATCCTTGGGACAGCAATAATAATGTGGCTTC
N.gonorrhoeae (variant) ...T...CT..G....................A.....A..........C.............................G..........
N.meningitidis (278) ...T...CT..G....................A.....A..........C.............................G..........
190       200       210       220       230       240       250 260       270
N.gonorrhoeae(FA1090) GCAATTGGGTATTTTCAAACGCCACGACGGTATGCCGGTTTCCGTGCGTTACGATTCCCCCGGATTTTCCGGTTTCAGCGGCAGCATTCA
N.gonorrhoeae (variant) .............................A...............A..C.....C..T..G.AC.....................G.C..
N.meningitidis (278) .............................A...............A..C.....C..T..G.AC.....................G.C..
280       290       300       310       320       330       340       350       360
N.gonorrhoeae(FA1090) ATTTGTTCCGAGTCAAAACAGCAAGTCCGCCTATACGCCTGCTACTTTCACGCTGGAAAGTAATCAGATGAAACCAGTTCCGGCTGTTGT
N.gonorrhoeae (variant) ...C......GC...........................G...-----T.T.-....T.AGG.G...G..---T.TCA.G..........
N.meningitidis ( 278) ...C......GC...........................G...-----T.T.-....TGAG..G...G..---T.TCA.G..........
370       380       390       400       410       420       430       440       450
N.gonorrhoeae (FA1090) CGGCAAGCCGGGGTCGGATGTGTATTATGCCGGTCTGAATTACAAAAATGGCGGCTTTTTCGGAAATTATGCCCTTAAATATGCGAAACA
N.gonorrhoeae (variant) .........C..A.........................................A...GC...G.GC......T................
N.meningitidis (278) .........C..A.........................................A...GC...G.GC......T................
460       470       480       490       500       510       520       530       540
N.gonorrhoeae (FA1090) CGCCAATGAGGGGCATGATGCTTTCTTTTTGTTCTTGCTCGGCAGAGCGAGTGAT------------ACCGATCCATTGAAAAACCATCA
N.gonorrhoeae (variant) ..............G..............................C.G.......GAAGCCAAAGGT........C..............
N.meningitidis (278) ..............G..............................C.G.......GAAGCCAAAGGT........C..............
550       560       570       580       590       600       610       620       630
N.gonorrhoeae (FA1090) GGTACACCGCCTGACGGGCGGCTATGGGGAAGGCGGCTTGAATCTCGCCTTGGCGGCTCAGTTGGATTTGTCTGAAAATGCCGACAAAAC
N.gonorrhoeae (variant) ..........................A...............................................................
N.meningitidis (278) ..........................A...............................................................
640       650       660       670       680       690       700       710       720
N.gonorrhoeae (FA1090) CAAAAACAGTACGACCGAAATTGCCGCCACTGCTTCCTACCGCTTCGGTAATACAGTCCCGCGCATCAGCTATGCCCATGGTTTCGACTT
N.gonorrhoeae (variant) ....................................................G....T................................
N.meningitidis (278) ....................................................G....T................................
730       740       750       760       770       780
N.gonorrhoeae (FA1090) TGTCGAACGCAGTCAGAAACGCGAACATACCAGCTATGATCAAATCATCGCCGGTGTCGATT
N.gonorrhoeae (variant) ..............................................................
N.meningitidis (278) .A........G..A.A...G.....A..........C.................C..T....
a Genbank accession AJ223447.
b Pseudogene PCR negative strain from this study.
c Genbank accession GQ173789.
Forward and reverse primer targets of the TaqMan-based Neisseria gonorhoeae porA pseudogene PCR are represented by arrows at positions 
262 to 284 and 324 to 250 respectively. 
The probe target is represented by the box at position 298 to 323.   
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flight mass spectrophotometer (MALDI TOF MS) Maldi 
Biotyper (Bruker Biosciences Pty Ltd.). Antimicrobial 
resistance patterns for these isolates were character-
istic of N. gonorrhoeae, as determined by the minimum 
inhibitory concentrations (MICs) using the agar plate 
incorporation method of the Australian Gonococcal 
Surveillance Programme and using the CDS Antibiotic 
Susceptibility criteria [10]. The clinical isolates had 
chromosomally-mediated penicillin resistance (MIC: 
2.0 mg/L), quinolone resistance (ciprofloxacin MIC: 16.0 
mg/L), decreased susceptibility to ceftriaxone (MIC: 
0.03 mg/L) and sensitivity to azithromycin and spec-
tinomycin. Both isolates were of multilocus sequence 
type (MLST) 1901 (abcZ 109, adk 39, aroE 170, fumC 111, 
gdh 148, pdhC 153, pgm 65). This is an N. gonorrhoeae 
MLST type previously observed in Australia and else-
where [11,12] and representatives of this type have pre-
viously provided positive results by porA-pseudogene 
PCR in our laboratory (data not shown). Using N. gon-
orrhoeae multi-antigen sequence typing (NG-MAST), 
both isolates harboured the previously described POR 
and tbpB types, 1297 and 983 respectively, which 
represented a novel NG-MAST type 5377. It should 
be noted that MLST and NG-MAST are not performed 
as a routine part of N. gonorrhoeae investigations in 
our laboratory, therefore isolates of these MLST and 
NG-MAST types may have previously been circulating 
in our population but not characterised. 
To examine the basis of the porA pseudogene PCR 
false-negative results, a 773 base-pair fragment 
of the porA sequences of each isolate were ampli-
fied using primers CGGCTCGTTTATCGGCTT and 
GGTATTTCGTTTCAGCCAAGC and subjected to DNA 
sequencing. The porA-pseudogene PCR-negative N. 
gonorrhoeae strains from this study exhibited only 
90% homology with the reference N. gonorrhoeae 
FA1090 strain (genbank accession number AJ223447) 
and had multiple mismatches and deletions evident 
in the primer and probe targets for the porA pseudog-
ene Taqman-based-PCR (Figure) and for the LightCycler 
hybridisation probe-based method targeting the same 
region (data not shown). 
Notably, genbank blast searching indicated that the 
porA sequence from the clinical isolates in this study 
were more similar to that of N. meningitidis, hav-
ing 99% homology with N. meningitidis 278 strain 
(Genbank accession GQ173789). Only the last 60 bases 
of the 773 base porA sequence provided greater homol-
ogy with N. gonorrhoeae than with N. meningitidis.
Conclusions
Overall the results show that the rectal and pha-
ryngeal N. gonorrhoeae isolates from this patient 
were typical in terms of genotypic and phenotypic 
characteristics, except that they had acquired a 
meningococcal porA sequence presumably through 
horizontal genetic exchange and recombination. This 
is yet another example of the problems faced with 
molecular detection of N. gonorrhoeae, and with 
PCR-based diagnostics more generally. For N. gon-
orrhoeae, the problem is exacerbated by the fact 
that the species comprises numerous subtypes that 
exhibit considerable sequence diversity as well as 
propensity to mutate. Notably, the distribution of 
subtypes can vary geographically, temporally, and 
between patient groups. This has implications for 
the performance of N. gonorrhoeae NAATs: firstly, 
the performance may vary between patient popula-
tions because of the presence of different subtypes; 
but secondly, as in our case, the performance within 
a given population can suddenly change either due to 
the importation of new strains or mutation of currently 
circulating strains. In our opinion, the use of different 
methods, such as NAAT and bacterial culture in par-
allel, or multi-target NAAT assays provides the most 
suitable means of circumventing these problems, and 
to this extent we have previously described a duplex 
real-time PCR assay for detecting N. gonorrhoeae 
combining both the porA pseudogene and opa targets 
[8]. To date, we have not observed any other N. gonor-
rhoeae isolates with a meningococcal porA sequence 
in our laboratory and to our best knowledge this has 
also not been observed elsewhere. Given the propen-
sity for gonococci to spread through populations, we 
consider it likely that this strain is more widespread. 
Further investigations including contact tracing and 
prospectively testing N. gonorrhoeae isolates by porA 
pseudogene PCR, are continuing.
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